An Israeli company that develops treatments for severe neurodegenerative diseases has patented a new therapeutic drug for Amyotrophic Lateral Sclerosis (ALS) in Europe, Japan and Israel. ALS is a progressive disease that causes the degeneration of motor neurons in the brain and spinal cord, eventually resulting in the inability to speak, eat, move and breathe. […]
